<DOC>
	<DOCNO>NCT02615015</DOCNO>
	<brief_summary>Neutrophil extracellular trap ( NETs ) deoxyribonuclease ( DNase ) activity determine outcome ST elevation acute coronary syndrome ( STE-ACS ) . DNase single nucleotide polymorphism ( SNPs ) increase japanese cohort . In present study , investigator seek measure DNase SNPs frequency caucasian STE-ACS cohort compare healthy control ( n=400 ) . The investigator compute polymorphism , DNase activity , NET surrogate marker clinical variable regression model .</brief_summary>
	<brief_title>SNPs DNase 1 Gene Impair Its Activity Are Increased STE-ACS Patient Cohort Compared Healthy Controls</brief_title>
	<detailed_description>Background Acute coronary syndrome ( ACS ) among lead cause death ( 1 ) . Atherosclerosis coronary thrombotic occlusion drive inflammatory pathomechanisms ( 2 ) . The investigator show neutrophilic activation neutrophil extracellular trap ( NETs ) culprit lesion site ST-elevation ACS ( STE-ACS ) patient ( 3 ) . NETs well describe component thrombus , build condensation nucleus platelet , erythrocytes fibrinogen . NET-containing thrombus effectively lysed deoxyribonuclease ( DNase ) vitro ( 4 ) . By add DNase , investigator show potent acceleration tissue plasminogen activator-mediated lysis coronary thrombus ex vivo . Surrogate marker NETs strong predictor acute coronary event ( 5 ) . In STE-ACS patient , NETs directly correlate cardiac magnet resonance-measured infarct size . Moreover , increase coronary DNase activity correlate small infarct size ( 3 ) . Two major endogenous plasmatic DNases describe , namely DNase 1 DNase gamma ( 6 ) . Several polymorphisms gene encode DNase 1 affect activity know ( 7,8 ) . The single nucleotide polymorphism ( SNP ) Q222R DNase 1 gene , lead impaired extracellular DNase activity , correlate increase incidence myocardial infarction Japanese patient ( 9 ) . SNPs associate reduced DNAse activity also know DNase gamma , association ACS investigate . Present data implicate critical balance formation degradation NETs outcome ACS . Rationale The investigator hypothesize coronary endoluminal NET formation major component acute macro- microvessel atherothrombosis . Extracellular DNase degrade NETs , thus down-regulating overwhelming NET formation . Impaired DNase activity increase risk ACS . Thus , investigator seek test presence polymorphism DNase gene impair DNase activity STE-ACS population . Aims 1 . To compare single nucleotide polymorphism DNase 1 gamma gene STE-ACS patient , coronary artery disease patient healthy control use polymerase chain reaction 2 . To test DNase activity plasma patient healthy control correlate respective gene expression type 3 . To test NET formation NET surrogate marker correlate DNase activity DNase SNPs 4 . To correlate data surrogate marker infarct size , reperfusion , long term outcome parameter risk factor coronary artery disease . Methods Patients The investigator contact patient ( n=400 ) hospitalize General Hospital Vienna past 10 year ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention ( pPCI ) TIMI 0-1 . These patient invite consultation . The investigator perform follow investigation patient willing join study : - Medical history - Detailed clinical examination - Electrocardiography - Echocardiography - Routine blood draw - Blood draw research experiment Any patient relevant clinical finding lead diagnostic evaluation . MACE occur acute coronary event presence survey consultation . All patient contact year assess MACE . Healthy donor Blood sample healthy donor ( n=400 ) obtain peripheral blood draw cubital vein . The probands recruit bulletin General Hospital Vienna . Real time polymerase chain reaction Cells lysed DNAwill isolate use DNAeasy kit ( Applied Biosystems ) . DNA analyze DNase SNPs use primer/probe assay ( Applied Biosystems ) . The ABI PRISM 7000 Sequence Detection System software ( Applied Biosystems ) use . NET surrogate marker determination Nucleosomes For detection DNA-histone complex ( nucleosomes ) , ELISA-Cell death detection kit ( Roche Diagnostics GmbH , Germany ) employ . Optical density ( OD ) value normalize internal positive control express arbitrary nucleosome units/ml ( NU/ml ) . The intra-assay positive control equal 1000 NU/ml . MPO-DNA complex Myeloperoxidase ( MPO ) -associated DNA fragment identify use capture ELISA . 96-well microplates coat anti-MPO monoclonal capturing antibody ( ABD Serotec , UK ) . As detection antibody , investigator use peroxidase label anti-DNA monoclonal antibody ( Cell Death Detection ELISA Plus Kit , Roche Diagnostics GmbH , Germany ) . All measurement perform duplicate value specify mean ODs . Double strand DNA For detection double strand DNA ( dsDNA ) patient plasma , investigator employ Quant-iT PicoGreen dsDNA Assay ( Invitrogen , USA ) 96-well microplates . PicoGreen fluorescent nucleic acid stain quantification dsDNA solution . Fluorescence measure Varioskan Flash microplate reader ( Thermo Scientific , USA ) normalize provide standard ( 1000 ng/ml ) . DNase activity assay Endogenous deoxyribonuclease ( DNase ) activity measure employ DNase Activity Assay ( Orgentec Diagnostika GmbH , Mainz , Germany ) . A DNA-coated microplate incubate plasma sample 60 minute . Coated DNA degrade proportion DNase activity respective sample . Optical density residual DNA inversely proportional DNase activity . All assay perform follow manufacturer´s instruction . All measurement perform duplicate . Plates read VersaMax microplate reader ( Molecular Devices , Sunnyvale , CA , USA ) . Polymorphonuclear ( PMN ) cell culture netosis assay PMNs ( i.e . mainly neutrophils ) healthy donor isolate Polymorphprep ( Axis-Shield , Dundee , Scotland ) . Erythrocytes lysed use one-step lysis buffer ( NH4Cl 154mmol/L , KHCO3 10mmol/L , EDTA 0.1mmol/L ) . The cell suspension wash twice HBSS supplement 10 % fetal calf serum ( FBS ) . Isolated PMNs count resuspend 2x10^6 cells/ml HBSS supplement 10 % FBS . Cell viability determine trypan blue exclusion . Immunofluorescence stain NETs Fixed NETs stain use mouse anti-DNA Histone H1 antibody ( Millipore ) . After incubation , secondary donkey anti-mouse IgG antibody couple Alexa Fluor 555 ( Invitrogen , Life Technologies , Grand Island , NY ; USA ) add . For detection nuclear DNA , 4',6-diamidino-2-phenylindole ( DAPI , Vectashield mount medium DAPI ; Vector Laboratories , Burlingame , CA , USA ) use . For stain neutrophil elastase ( NE ) myeloperoxidase ( MPO ) , rabbit anti-human NE MPO antibody ( Abcam ) use secondary Alexa Fluor 488 couple donkey anti-rabbit IgG antibody ( Invitrogen ) . Images obtain Axio Imager 2 fluorescence microscope use AxioVision ( Carl Zeiss Microscopy GmbH , Göttingen , Germany ) . Statistics Normally distribute data express mean ± standard deviation ( SD ) , otherwise median interquartile range ( IQR ) present . Paired Students t-test applied compare normally distribute variable , otherwise Wilcoxon sign rank test use . Distribution data test use Kolmogorov-Smirnov test , Shapiro-Wilk test histogram ( data show ) . For comparison multiple group , one-way analysis variance post-hoc Scheffé-procedure performed . Spearman 's rank correlation ( r ) apply calculate correlation data . Multivariate regression model calculate bootstrap correction technique apply . The area curve ( AUC ) CK-MB value express arbitrary unit calculate employ trapezoidal formula ( 10 ) , least 5 consecutive value period 3 day post admission available . Bonferroni-Holm correction use multiple testing . A p-value 0.05 consider significant . Statistical analysis perform use IBM SPSS Statistics 20.0 Windows ( New York , NY , USA ) . Figures generate use GraphPad Prism 5 .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Medical history Detailed clinical examination Electrocardiography Echocardiography Routine blood draw ( differential blood count , clot factor include fibrinogen , liver enzymes , creatine kinase ( CK ) , CKMB , Creactive protein ( CRP ) , Nterminal probrain natriuretic peptide ( NTproBNP ) , HbA1c Blood draw research experiment Patients 18 year ; autoimmune disease , immunemodulating medication , systemic infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Deoxyribonuclease</keyword>
</DOC>